Updated Oct 10, 2026 · 08:31 UTC
EXELExelixis, Inc.
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$60.06+1.42%last session · market closed
Market cap
$14.88b
real-world
Tokenized
$59
<0.001% of the asset
Avg token price
$59.33
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
EXEL · Price
Apr 29, 2025low $35.05 · high $59.00 · now $59.00Oct 9, 2026
EarningsNasdaq’s earnings calendar
Next earnings
Nov 3
estimated date · Sep 2026 quarter · EPS forecast $0.79 (5 analysts)
Last earnings, Aug 5
$0.82 EPS
+9.3% vs $0.75 forecast · Jun 2026 quarter
Real marketExelixis Inc
Last close
$59.02
Oct 8
Traded on Oct 8
$158.7m
Price now
$60.06
market closed
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions1 token from 1 issuer
wEXELxBacked Assets——In DeFiPools and lending markets that hold these tokens
None found
Business 12 months to Jul 2026 · SEC EDGAR
Results
Revenue
$2.44b
+9% YoY
Operating income
$971.5m
40% margin · +39% YoY
Net income
$860.7m
35% margin · +43% YoY
EPS, diluted
$3.31
+56% YoY
Diluted shares
260m
−9% YoY
Cash and balance sheet
Free cash flow
$1.17b
48% of revenue · 7.9% yield
Cash and securities
$1.38b
debt not tagged
Quarterly
RevenueNet income
Valuation today’s market cap $14.88b
P/E
17.3×
P/S
6.1×